✦ LIBER ✦

Efficacy and safety of boosted atazanavir in HIV-infected, ARV-naive patients — results from 48/96 weeks Castle study

✍ Scribed by Ewa Siwak; Tomasz Mikula; Wojciech Stańczak; Alicja Wiercinska-Drapalo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily atazanavir/ritonavir versus t

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

PIN54 COST-EFFECTIVENESS ANALYSES (CEA)

✍ Simpson, K; Baran, R; Woodward, C; Dietz, B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PIN37 COST EFFECTIVENESS ANALYSES (CEA)

✍ KN Simpson; B Dietz; RW Baran; SE Kirbach; T Podsadecki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Efficacy and safety of TMC125 (etravirin

✍ José Valdez Madruga; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob Lal 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Efficacy and safety of TMC125 (etravirin

✍ Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christi 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Efficacy and safety of darunavir-ritonav

✍ Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 180 KB